ProShare Advisors’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.6K | Sell |
|
|||||
|
2025
Q1 | $71.7K | Sell |
|
|||||
|
2024
Q4 | $138K | Buy |
|
|||||
|
2024
Q3 | $58.9K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $22.2K | Sell |
|
|||||
|
2022
Q4 | $97.1K | Buy |
|
|||||
|
2022
Q3 | $88K | Buy |
|
|||||
|
2022
Q2 | $76K | Sell |
|
|||||
|
2022
Q1 | $81K | Buy |
|
|||||
|
2021
Q4 | $50K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $251K | Buy |
|
|||||
|
2021
Q1 | $302K | Buy |
|
|||||
|
2020
Q4 | $261K | Buy |
|
|||||
|
2020
Q3 | $285K | Sell |
|
|||||
|
2020
Q2 | $407K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $557K | Sell |
|
|||||
|
2019
Q3 | $374K | Sell |
|
|||||
|
2019
Q2 | $478K | Sell |
|
|||||
|
2019
Q1 | $466K | Buy |
|
|||||
|
2018
Q4 | $529K | Sell |
|
|||||
|
2018
Q3 | $609K | Sell |
|
|||||
|
2018
Q2 | $559K | Sell |
|
|||||
|
2018
Q1 | $1.05M | Sell |
|
|||||
|
2017
Q4 | $1.09M | Buy |
|
|||||
|
2017
Q3 | $784K | Buy |
|
|||||
|
2017
Q2 | $598K | Sell |
|
|||||
|
2017
Q1 | $483K | Sell |
|
|||||
|
2016
Q4 | $215K | Buy |
|
|||||
|
2016
Q3 | $217K | Sell |
|
|||||
|
2016
Q2 | $183K | Buy |
|
|||||
|
2016
Q1 | $309K | Sell |
|
|||||
|
2015
Q4 | $446K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $240K | Sell |
|
|||||
|
2014
Q2 | $184K | Sell |
|
|||||
|
2014
Q1 | $248K | Buy |
|